Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 16 May, 2014 and appeared in  ObesityPublic HealthIssue 729

AACE Announces a New Medically-Actionable Diagnosis of Obesity

An advanced framework for a new diagnostic approach to obesity was announced last week by the American Association of Clinical Endocrinologists (AACE) at their 23rd Scientific and Clinical Congress.... 

Advertisement

An emergent concept from the Consensus Conference on Obesity, convened by AACE and the American College of Endocrinology (ACE) in March 2014, was that the current diagnostic definition of obesity, which relied on an anthropomorphic measure of body mass index (BMI), needed to be updated. BMI alone does not indicate how weight gain might be affecting the health of individual patients, and multiple stakeholders at the Consensus Conference saw this as a major obstacle to concerted action in combatting obesity.

The new obesity definition and diagnostic strategy is actionable, medically-meaningful and adds value to the health-promoting effects of weight loss.

Dr. W. Timothy Garvey, Chair of the AACE/ACE Consensus Conference on Obesity and Obesity Scientific Committee and author of the AACE/ACE Obesity Consensus Statement, added that, "This approach addresses a problem of diagnostic uncertainty and is the first step in removing the impediment for concerted and comprehensive action among health care professionals, health care systems, regulators, payers, and employers."

In 2011, AACE/ACE declared obesity as a chronic disease as did the American Medical Association in June 2013.

The new approach does not simply depend upon BMI alone, but also the impact of weight gain on health. A four-step approach is recommended for all patients: screening using BMI with adjustments for ethnic differences, clinical evaluation for the presence of obesity-related complications using a checklist, staging for the severity of complications using complication-specific criteria, and selection of prevention and/or intervention strategies targeting specific complications as guided by the AACE/ACE obesity management algorithm.

The next steps will be to obtain broad input and recommendations regarding the framework for the new diagnostic approach from participants at the Consensus Conference on Obesity. The goal is to assure broad-based acceptance, translation, and implementation of the diagnosis that will support concerted action around a rational and comprehensive plan to prevent and treat obesity.

Presented at the 2015 Meeting of the American Association of Clinical Endocrinologists. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 16 May, 2014 and appeared in  ObesityPublic HealthIssue 729

Past five issues: Diabetes Clinical Mastery Series Issue 208 | Issue 748 | GLP-1 Special Editions September 2014 | Diabetes Clinical Mastery Series Issue 207 | Issue 747 |

2014 Most Popular Articles:

Abbott Announces Approval of Its New Unique Continuous Glucose Monitor
Posted September 05, 2014
Low Carb Beats Low Fat
Posted September 05, 2014
FDA Approves Bupropion/Naltrexone (Contrave) for Obesity by Orexigen Therapeutics
Posted September 12, 2014
Lilly's Basal Insulin Peglispro Demonstrated HbA1c Superiority against Lantus
Posted September 05, 2014
An Exclusive Interview with Al Mann, Founder and CEO, Mannkind Corp.
Posted September 15, 2014
Empagliflozin (Jardiance) SGLT-2 Inhibitor Now Available in Pharmacies
Posted August 29, 2014
Sleeve Gastrectomy Now a Common Choice for Bariatric Surgery
Posted September 12, 2014
Predicting Which Diabetics Will Develop Major Complications
Posted September 05, 2014
Type 2 Diabetes Diagnosis Needs to Be Changed: Prediabetes=Diabetes
Posted September 12, 2014
No Cancer Link to Actos Long Term
Posted September 05, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Now that once-weekly dulaglutide has been approved, will you be prescribing it?
CME/CE of the Week
Warren Joseph, DPM, FIDSA

Category: Wound Care
Credits: .75



Search Articles On Diabetes In Control